News

UTSW receives national recognition

UTSW receives national recognition

U.S. News & World Report just released its 2017 list of top hospitals. UT Southwestern ranks #1 in the Dallas/Ft. Worth area and #2 in Texas. In addition, we nationally ranked in six specialties and are noted as high-performing in four conditions, including cancer. An honor to be recognized!

A new chapter in radiation oncology

A new chapter in radiation oncology

UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center is one of the nation’s top destinations for patients seeking cancer treatments. Now it has a new radiation oncology building to call home that’s as sterling as its reputation.

High-tech radiation oncology building opens its doors

High-tech radiation oncology building opens its doors

UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center is one of the nation’s top destinations for patients seeking cancer treatments. Now it has a new radiation oncology building to call home that’s as sterling as its reputation.

Researchers uncover mechanism for cancer-killing properties of pepper plant

Researchers uncover mechanism for cancer-killing properties of pepper plant

UT Southwestern Medical Center scientists have uncovered the chemical process behind anti-cancer properties of a spicy Indian pepper plant called the long pepper, whose suspected medicinal properties date back thousands of years.

Cancer investigators receive major donor-funded grants for combined immunotherapy and radiation research

Cancer investigators receive major donor-funded grants for combined immunotherapy and radiation research

Neil Desai, M.D., Ph.D., Assistant Professor of Radiation Oncology, has been appointed a Dedman Family Scholar in Clinical Care, an honor that comes with a $600,000, four-year grant. Two other physician-led grants were awarded by the Lupe Murchison Foundation and the Once Upon a Time Foundation.

Role for SABR in metastatic renal cell cancer

Role for SABR in metastatic renal cell cancer

Dr. Raquibul Hannan is interviewed on Cancer Network about stereotactic ablative radiotherapy (SABR) for advanced kidney cancer.

Speaker roundup for September

Speaker roundup for September

Department of Radiation Oncology faculty gave invited lectures at the following events recently:

New faculty members and promotions in Radiation Oncology

New faculty members and promotions in Radiation Oncology

Andrei Pugachev, Ph.D., is a new Assistant Professor in our Physics Division, while Heeyoun Bunch, Ph.D., joins the Molecular Radiation Biology Division as an Instructor.

New laboratory opens under Davis

New laboratory opens under Davis

Assistant Professor Tony Davis, Ph.D., has been made an independent in­vestigator in the department’s Division of Molecular Radiation Biology.

Neutrophils are key to harnessing anti-tumor immune response from radiation therapy, study finds

Neutrophils are key to harnessing anti-tumor immune response from radiation therapy, study finds

Combining targeted radiation therapy with a neutrophil stimulant enhances anti-tumor immunity, according to new research into cancer immunology at UT Southwestern Medical Center

Grants awarded to Radiation Oncology researchers

Grants awarded to Radiation Oncology researchers

Grants totalling more than $2.6 million have been awarded to researchers in medical physics and molecular radiation biology.

Speaker roundup for June

Speaker roundup for June

Department of Radiation Oncology faculty gave invited lectures at the following events recently:

Texans want in on cancer "moonshot"

Texans want in on cancer "moonshot"

Our heavy ion initiative was highlighted during a national summit on cancer led by Vice President Joe Biden.

Department makes heavy ion grant awards

Department makes heavy ion grant awards

The Department of Radiation Oncology at UT Southwestern Medical Center has awarded five, two-year seed grants of $100,000 apiece to Texas researchers to facilitate research related to heavy ion therapy.

NASA awards funds to study effects of space radiation during Mars mission

NASA awards funds to study effects of space radiation during Mars mission

UT Southwestern Medical Center researchers have been awarded $3.6 million in NASA funds to study how space radiation would affect the cancer risk of astronauts taking part in deep space missions to Mars.

With CPRIT grants, new approaches for pediatric cancer treatment

With CPRIT grants, new approaches for pediatric cancer treatment

Investigators in the Department of Radiation Oncology were awarded close to $2.7 million in the latest round of funding from the Cancer Prevention and Research Institute of Texas (CPRIT) to study and treat childhood cancer.

Researchers develop classification model for cancers caused by most frequently mutated cancer gene

Researchers develop classification model for cancers caused by most frequently mutated cancer gene

UT Southwestern Medical Center researchers have developed a classification for cancers caused by KRAS, the most frequently mutated gene in cancer, that could eventually help oncologists choose more effective, customized cancer therapies.

UTSW receives key NCI funding to plan first U.S. Center for Heavy Ion Radiation Therapy Research

UTSW receives key NCI funding to plan first U.S. Center for Heavy Ion Radiation Therapy Research

The National Cancer Institute (NCI) of the National Institutes of Health awarded UT Southwestern a $1 million planning grant to establish the country’s first National Center for Heavy Ion Radiation Therapy.

Cancer researchers identify irreversible inhibitor for KRAS gene mutation

Cancer researchers identify irreversible inhibitor for KRAS gene mutation

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

Blocking DNA repair could improve radiation therapy for brain cancer

Blocking DNA repair could improve radiation therapy for brain cancer

UT Southwestern Medical Center researchers have demonstrated in both cancer cell lines and in mice that blocking critical DNA repair mechanisms could improve the effectiveness of radiation therapy for highly fatal brain tumors called glioblastomas.